Sunder Mudaliar
Researcher Next ID · RN-025303
Researcher · Medicine
San Diego, Peru
- Works count
- 167
- Citation count
- 15,974
- H-index
- 57
- i10-index
- 117
Research interests
Publications
Effect of canagliflozin treatment on hepatic triglyceride content and glucose metabolism in patients with type 2 diabetes
Diabetes Obesity and Metabolism · 2018 · https://doi.org/10.1111/dom.13584
Sodium–Glucose Cotransporter Inhibitors: Effects on Renal and Intestinal Glucose Transport
Diabetes Care · 2015 · https://doi.org/10.2337/dc15-0642
Efficacy and Safety of the Farnesoid X Receptor Agonist Obeticholic Acid in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease
Gastroenterology · 2013 · https://doi.org/10.1053/j.gastro.2013.05.042
Canagliflozin Lowers Postprandial Glucose and Insulin by Delaying Intestinal Glucose Absorption in Addition to Increasing Urinary Glucose Excretion
Diabetes Care · 2013 · https://doi.org/10.2337/dc12-2391
Hyperglycemia Associated With Pasireotide: Results From a Mechanistic Study in Healthy Volunteers
The Journal of Clinical Endocrinology & Metabolism · 2013 · https://doi.org/10.1210/jc.2013-1771
Pioglitazone for Diabetes Prevention in Impaired Glucose Tolerance
New England Journal of Medicine · 2011 · https://doi.org/10.1056/nejmoa1010949
Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
The Lancet · 2010 · https://doi.org/10.1016/s0140-6736(10)60888-4
Pioglitazone: side effect and safety profile
Expert Opinion on Drug Safety · 2010 · https://doi.org/10.1517/14740331003623218
Effect of the dual peroxisome proliferator-activated receptor-α/γ agonist aleglitazar on risk of cardiovascular disease in patients with type 2 diabetes (SYNCHRONY): a phase II, randomised, dose-ranging study
The Lancet · 2009 · https://doi.org/10.1016/s0140-6736(09)60870-9
Intensive Glucose-Lowering Therapy Reduces Cardiovascular Disease Events in Veterans Affairs Diabetes Trial Participants With Lower Calcified Coronary Atherosclerosis
Diabetes · 2009 · https://doi.org/10.2337/db09-0618
Impact of atypical antipsychotic therapy on leptin, ghrelin, and adiponectin
Schizophrenia Research · 2008 · https://doi.org/10.1016/j.schres.2007.11.026
Assessment of Capacity to Consent to Research Among Older Persons With Schizophrenia, Alzheimer Disease, or Diabetes Mellitus
Archives of General Psychiatry · 2005 · https://doi.org/10.1001/archpsyc.62.7.726
Thiazolidinediones, Peripheral Edema, and Type 2 Diabetes: Incidence, Pathophysiology, and Clinical Implications
Endocrine Practice · 2003 · https://doi.org/10.4158/ep.9.5.406
Modulation of Circulating and Adipose Tissue Adiponectin Levels by Antidiabetic Therapy
Diabetes · 2003 · https://doi.org/10.2337/diabetes.52.3.667
Utility of B-Type Natriuretic Peptide (BNP) as a Screen for Left Ventricular Dysfunction in Patients With Diabetes
Diabetes Care · 2003 · https://doi.org/10.2337/diacare.26.7.2081
Inhaled Insulin Using the AERx Insulin Diabetes Management System in Healthy and Asthmatic Subjects
Diabetes Care · 2003 · https://doi.org/10.2337/diacare.26.3.764
Differential Effects of Metformin and Troglitazone on Cardiovascular Risk Factors in Patients With Type 2 Diabetes
Diabetes Care · 2002 · https://doi.org/10.2337/diacare.25.3.542
Inhibition of Glycogen Synthase Kinase 3 Improves Insulin Action and Glucose Metabolism in Human Skeletal Muscle
Diabetes · 2002 · https://doi.org/10.2337/diabetes.51.7.2190
New Oral Therapies for Type 2 Diabetes Mellitus: The Glitazones or Insulin Sensitizers
Annual Review of Medicine · 2001 · https://doi.org/10.1146/annurev.med.52.1.239
Distribution of peroxisome proliferator-activated receptors (PPARs) in human skeletal muscle and adipose tissue: relation to insulin action
Diabetologia · 2000 · https://doi.org/10.1007/s001250050048
Potential role of glycogen synthase kinase-3 in skeletal muscle insulin resistance of type 2 diabetes.
Diabetes · 2000 · https://doi.org/10.2337/diabetes.49.2.263
Insulin aspart (B28 asp-insulin): a fast-acting analog of human insulin: absorption kinetics and action profile compared with regular human insulin in healthy nondiabetic subjects.
Diabetes Care · 1999 · https://doi.org/10.2337/diacare.22.9.1501
Acute and Chronic Effect of Insulin on Leptin Production in Humans: Studies In Vivo and In Vitro
Diabetes · 1996 · https://doi.org/10.2337/diab.45.5.699
Current projects
No projects listed.